Join us for a virtual information session to learn more about Conscience’s Developing Medicines through Open Science (DMOS) program, where you can gain insights into the program’s goals, application process, and how it can support your research efforts.
The schedule will include an overview of the DMOS program, information on how to apply, and a Q&A session. This session is intended for researchers, organizations, and companies interested in applying for the DMOS program.
The session will take place on Zoom and will be recorded.
About DMOS
The DMOS program funds projects to develop therapeutics in areas of market failure – including orphan/rare disease and antimicrobial resistance. All projects must agree to operate according to open science principles.
Program Highlights
- DMOS funds research conducted from Technology Readiness Levels 2-6
- Total first round funding is $5 Million CAD
- Applications must include at least one Canadian SME
- Projects must agree to operate according to open science principles
- A one-page Letter of Intent describing proposed projects must be submitted through Conscience’s application portal by September 27, 2024
- Selected projects will be asked to submit a full proposal by November 22, 2024
